Insulet Corp Financials
Insulet Corp (PODD) reported $2.7B in revenue for fiscal year 2025, up 30.7% from the prior fiscal year. This page shows its income statement, balance sheet, cash flow statement, and key financial ratios. View 15 years of annual fundamentals and quarterly data, with year-over-year growth rates and compound annual growth rates (CAGR). All figures are derived from SEC filings (10-K and 10-Q reports).
Insulet’s recent story is scale-driven margin expansion turning a once debt-heavy balance sheet into a cash-generating growth engine.
FY2025’s net income fell to$247.1M from$418.3M , yet the business still produced higher operating cash flow and higher operating profit. That disconnect was driven largely by the tax line flipping from-$118.1M in FY2024 to$92.4M in FY2025, so the weaker bottom line says more about below-operating-line effects than about the core operating engine.
From the FY2022 margin trough to FY2025, gross margin expanded from
The balance sheet has been repaired quickly: debt-to-equity fell from 2.9x in FY2022 to 0.6x in FY2025, as long-term debt came down and retained earnings turned positive. With free cash flow at
Financial Health Signals
Scored against operating companies for FY2025. Each of the six dimensions is a percentile rank within that peer group; the overall is their average, with missing dimensions counted as zero out of six. A high score means strong standing among peers, not absolute cross-industry strength. How this score is calculated →
Health score ≠ stock price. This rates the quality of Insulet Corp's business: profitability, growth, balance sheet strength. It doesn't tell you whether the stock is a good buy at today's price. Not financial advice. Use it alongside valuation analysis and your own research.
Insulet Corp has an operating margin of 17.5%, meaning the company retains $18 of operating profit per $100 of revenue. This strong profitability earns a score of 75/100, reflecting efficient cost management and pricing power. This is up from 14.9% the prior year.
Insulet Corp's revenue surged 30.7% year-over-year to $2.7B, reflecting rapid business expansion. This strong growth earns a score of 87/100.
Insulet Corp has a moderate D/E ratio of 0.61. This balance of debt and equity financing earns a leverage score of 64/100.
With a current ratio of 2.81, Insulet Corp holds $2.81 in current assets for every $1 of short-term obligations. This comfortable liquidity earns a score of 74/100.
Insulet Corp converts 14.0% of revenue into free cash flow ($377.7M). This strong cash generation earns a score of 73/100.
Insulet Corp earns a strong 16.3% return on equity (ROE), meaning it generates $16 of profit for every $100 of shareholders' equity. This efficient capital use earns a returns score of 73/100. This is down from 34.5% the prior year.
Insulet Corp scores 5.69, well above the 2.99 safe threshold. The score is driven primarily by a large market capitalization ($10.5B) relative to total liabilities ($1.7B). This indicates low bankruptcy risk based on profitability, leverage, and asset efficiency.
Distress-screening estimate for non-financial companies. Not computed for banks or insurers, where the Altman model does not apply.
Insulet Corp passes 6 of 9 financial strength tests. 3 of 4 profitability signals pass, 1 of 3 leverage/liquidity signals pass, both operating efficiency signals pass.
For every $1 of reported earnings, Insulet Corp generates $2.30 in operating cash flow ($569.3M OCF vs $247.1M net income). This indicates profits are well-supported by actual cash generation, not accounting adjustments.
Insulet Corp earns $7.98 in operating income for every $1 of interest expense ($473.8M vs $59.4M). This wide margin provides strong safety for debt servicing, even if earnings decline temporarily.
Key Financial Metrics
Earnings & Revenue
Insulet Corp generated $2.7B in revenue in fiscal year 2025. This represents an increase of 30.7% from the prior year.
Insulet Corp's EBITDA was $564.2M in fiscal year 2025, measuring earnings before interest, taxes, depreciation, and amortization. This represents an increase of 44.8% from the prior year.
Insulet Corp reported $247.1M in net income in fiscal year 2025. This represents a decrease of 40.9% from the prior year.
Insulet Corp earned $3.48 per diluted share (EPS) in fiscal year 2025. This represents a decrease of 39.8% from the prior year.
Cash & Balance Sheet
Insulet Corp generated $377.7M in free cash flow in fiscal year 2025, representing cash available after capex. This represents an increase of 23.7% from the prior year.
Insulet Corp held $716.1M in cash against $930.8M in long-term debt as of fiscal year 2025.
Not reported for fiscal year 2025.
Margins & Returns
Insulet Corp's gross margin was 71.6% in fiscal year 2025, indicating the percentage of revenue retained after direct costs. This is up 1.8 percentage points from the prior year.
Insulet Corp's operating margin was 17.5% in fiscal year 2025, reflecting core business profitability. This is up 2.6 percentage points from the prior year.
Insulet Corp's net profit margin was 9.1% in fiscal year 2025, showing the share of revenue converted to profit. This is down 11.1 percentage points from the prior year.
Insulet Corp's ROE was 16.3% in fiscal year 2025, measuring profit generated per dollar of shareholder equity. This is down 18.2 percentage points from the prior year.
Capital Allocation
Insulet Corp invested $301.1M in research and development in fiscal year 2025. This represents an increase of 37.1% from the prior year.
Insulet Corp spent $59.6M on share buybacks in fiscal year 2025, returning capital to shareholders by reducing shares outstanding.
Insulet Corp invested $191.6M in capex in fiscal year 2025, funding long-term assets and infrastructure. This represents an increase of 53.4% from the prior year.
PODD Income Statement
Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type.
| Metric | TTM | FY25 | FY24 | FY23 | FY22 | FY21 | FY20 | FY19 | FY18 | FY17 | FY16 | FY15 | FY14 | FY13 | FY12 | FY11 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $3.1B | $2.7B+30.7% | $2.1B+22.1% | $1.7B+30.0% | $1.3B+18.8% | $1.1B+21.5% | $904.4M+22.5% | $738.2M+30.9% | $563.8M+21.6% | $463.8M+26.4% | $367.0M+39.1% | $263.9M+14.1% | $231.3M+24.9% | $185.1M-12.4% | $211.4M+38.8% | $152.3M |
| Cost of Revenue | $883.2M | $768.2M+22.7% | $625.9M+16.5% | $537.2M+7.5% | $499.7M+44.1% | $346.7M+7.6% | $322.1M+24.9% | $257.9M+33.2% | $193.6M+3.8% | $186.6M+19.7% | $155.9M+19.4% | $130.6M+25.4% | $104.2M+9.3% | $95.4M-19.9% | $119.0M+39.1% | $85.5M |
| Gross Profit | $2.2B | $1.9B+34.2% | $1.4B+24.6% | $1.2B+44.0% | $805.6M+7.1% | $752.1M+29.2% | $582.3M+21.2% | $480.3M+29.7% | $370.2M+33.5% | $277.2M+31.3% | $211.1M+58.4% | $133.3M+4.8% | $127.1M+41.6% | $89.8M-2.8% | $92.3M+38.4% | $66.7M |
| R&D Expenses | $345.9M | $301.1M+37.1% | $219.6M+7.1% | $205.0M+13.8% | $180.2M+12.6% | $160.1M+9.1% | $146.8M+11.0% | $132.3M+39.6% | $94.8M+25.2% | $75.7M+35.9% | $55.7M+28.9% | $43.2M+54.9% | $27.9M+28.2% | $21.8M-10.6% | $24.4M+11.4% | $21.9M |
| SG&A Expenses | $1.3B | $1.2B+27.0% | $917.2M+24.8% | $734.8M+25.0% | $587.8M+26.1% | $466.0M+21.4% | $384.0M+28.9% | $298.0M+20.2% | $248.0M+192.8% | $84.7M+18.3% | $71.6M+18.6% | $60.4M+4.9% | $57.5M+16.2% | $49.5M-3.4% | $51.2M+16.2% | $44.1M |
| Operating Income | $515.7M | $473.8M+53.4% | $308.9M+40.3% | $220.1M+485.4% | $37.6M-70.2% | $126.0M+144.7% | $51.5M+3.0% | $50.0M+82.5% | $27.4M+470.3% | -$7.4M+30.9% | -$10.7M+78.0% | -$48.7M-449.2% | -$8.9M+66.7% | -$26.7M+25.8% | -$36.0M+15.3% | -$42.5M |
| Interest Expense | $58.8M | $59.4M+39.1% | $42.7M+18.0% | $36.2M+0.6% | $36.0M-41.7% | $61.7M+28.3% | $48.1M+39.0% | $34.6M+19.7% | $28.9M+36.3% | $21.2M+47.3% | $14.4M+13.2% | $12.7M-12.8% | $14.6M-13.7% | $16.9M+2.9% | $16.4M+11.5% | $14.7M |
| Income Tax | $119.4M | $92.4M+178.2% | -$118.1M-1522.9% | $8.3M+59.6% | $5.2M+40.5% | $3.7M+27.6% | $2.9M0.0% | $2.9M+52.6% | $1.9M+850.0% | $200K-49.0% | $392K+84.9% | $212K+253.3% | $60K+172.7% | $22K-89.6% | $212K+101.9% | -$11.2M |
| Net Income | $375.3M | $247.1M-40.9% | $418.3M+102.8% | $206.3M+4384.8% | $4.6M-72.6% | $16.8M+147.1% | $6.8M-41.4% | $11.6M+251.5% | $3.3M+112.3% | -$26.8M+7.2% | -$28.9M+60.7% | -$73.5M-42.8% | -$51.5M-14.5% | -$45.0M+13.3% | -$51.9M-13.2% | -$45.8M |
| EPS (Diluted) | — | $3.48-39.8% | $5.78+96.6% | $2.94+4100.0% | $0.07-70.8% | $0.24+140.0% | $0.10-47.4% | $0.19+280.0% | $0.05+110.9% | -$0.46+4.2% | -$0.48 | N/A | N/A | N/A | N/A | N/A |
TTM is the trailing twelve months, Q3 FY2025 through Q2 FY2026, summed from the four most recent quarterly filings. A row marked — cannot be summed at all, because a quarter in the window reports no per-share figure; a row marked N/A could be summed, but a quarter in the window does not report that metric.
PODD Balance Sheet
Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type.
| Metric | FY25 | FY24 | FY23 | FY22 | FY21 | FY20 | FY19 | FY18 | FY17 | FY16 | FY15 | FY14 | FY13 | FY12 | FY11 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total Assets | $3.2B+3.3% | $3.1B+19.3% | $2.6B+15.0% | $2.3B+9.9% | $2.0B+9.4% | $1.9B+63.9% | $1.1B+23.1% | $928.7M+13.7% | $816.7M+78.9% | $456.6M+66.0% | $275.1M-7.4% | $297.2M+3.2% | $288.0M+45.4% | $198.1M-10.5% | $221.3M |
| Current Assets | $1.9B+1.2% | $1.9B+19.5% | $1.6B+20.5% | $1.3B-1.2% | $1.3B+6.5% | $1.2B+111.3% | $591.0M+28.1% | $461.3M-14.1% | $537.2M+45.2% | $370.0M+93.9% | $190.8M-8.4% | $208.2M+5.0% | $198.2M+80.3% | $109.9M-17.1% | $132.6M |
| Cash & Equivalents | $716.1M-24.9% | $953.4M+35.4% | $704.2M+2.1% | $689.8M-14.5% | $806.4M-11.1% | $907.2M+324.5% | $213.7M+87.6% | $113.9M-58.2% | $272.6M+98.7% | $137.2M+11.8% | $122.7M-18.9% | $151.2M+1.0% | $149.7M+161.3% | $57.3M-39.0% | $94.0M |
| Inventory | $452.6M+5.2% | $430.4M+6.9% | $402.6M+16.1% | $346.8M+14.4% | $303.2M+96.5% | $154.3M+52.8% | $101.0M+41.5% | $71.4M+111.3% | $33.8M-4.8% | $35.5M+195.4% | $12.0M+5.0% | $11.4M+21.0% | $9.5M-36.3% | $14.9M+25.6% | $11.8M |
| Accounts Receivable | $516.9M | N/A | N/A | $140.9M+4.2% | $135.2M+41.9% | $95.3M+37.5% | $69.3M+9.5% | $63.3M+18.6% | $53.4M+85.3% | $28.8M-32.3% | $42.5M+20.7% | $35.2M+6.6% | $33.1M-0.7% | $33.3M+43.6% | $23.2M |
| Goodwill | $51.6M+0.2% | $51.5M-0.4% | $51.7M0.0% | $51.7M+29.9% | $39.8M0.0% | $39.8M0.0% | $39.8M+0.5% | $39.6M-0.5% | $39.8M+0.3% | $39.7M+0.2% | $39.6M+5.9% | $37.4M0.0% | $37.4M-0.4% | $37.5M0.0% | $37.5M |
| Total Liabilities | $1.7B-10.7% | $1.9B+1.1% | $1.9B+4.6% | $1.8B+18.9% | $1.5B+17.6% | $1.3B+19.0% | $1.1B+48.9% | $716.6M+8.9% | $658.2M+67.3% | $393.5M+63.2% | $241.1M+13.0% | $213.4M+30.6% | $163.4M+6.2% | $153.9M+11.0% | $138.6M |
| Current Liabilities | $680.1M+28.7% | $528.4M+17.1% | $451.2M+23.7% | $364.7M+59.4% | $228.8M+10.1% | $207.8M+31.8% | $157.7M+36.3% | $115.7M+34.5% | $86.0M+54.5% | $55.7M-14.5% | $65.2M+47.1% | $44.3M+4.5% | $42.4M-12.2% | $48.3M+72.5% | $28.0M |
| Long-Term Debt | $930.8M-28.2% | $1.3B-5.1% | $1.4B-0.6% | $1.4B+10.0% | $1.2B+19.7% | $1.0B+17.5% | $887.9M+50.0% | $592.0M+4.6% | $566.2M+70.1% | $332.8M+93.8% | $171.7M+4.7% | $164.0M+44.3% | $113.7M+9.6% | $103.7M-4.4% | $108.5M |
| Total Equity | $1.5B+25.1% | $1.2B+65.4% | $732.7M+53.8% | $476.4M-14.4% | $556.3M-7.8% | $603.6M+695.3% | $75.9M-64.2% | $212.1M+33.8% | $158.5M+151.2% | $63.1M+85.3% | $34.1M-59.4% | $83.8M-32.7% | $124.6M+182.0% | $44.2M-46.6% | $82.7M |
| Retained Earnings | $287.4M+613.2% | $40.3M+110.7% | -$378.0M+35.3% | -$584.3M+10.0% | -$649.5M+2.5% | -$666.3M+0.8% | -$672.0M+1.7% | -$683.6M+3.3% | -$707.3M-3.9% | -$680.4M-4.4% | -$651.5M-12.7% | -$578.0M-9.8% | -$526.5M-9.3% | -$481.6M-12.1% | -$429.7M |
PODD Cash Flow Statement
Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type.
| Metric | TTM | FY25 | FY24 | FY23 | FY22 | FY21 | FY20 | FY19 | FY18 | FY17 | FY16 | FY15 | FY14 | FY13 | FY12 | FY11 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | $511.2M | $569.3M+32.3% | $430.2M+195.3% | $145.7M+22.4% | $119.0M+274.7% | -$68.1M-181.1% | $84.0M-14.6% | $98.4M+174.1% | $35.9M-13.1% | $41.3M+159.6% | $15.9M+226.8% | -$12.6M-240.7% | $8.9M+166.4% | $3.3M+111.5% | -$29.1M-14.2% | -$25.5M |
| Capital Expenditures | $217.5M | $191.6M+53.4% | $124.9M+65.2% | $75.6M-38.5% | $122.9M+9.8% | $111.9M-13.3% | $129.0M-21.2% | $163.7M+4.0% | $157.4M+113.3% | $73.8M+233.7% | $22.1M+108.5% | $10.6M-7.6% | $11.5M+57.2% | $7.3M-33.5% | $11.0M-1.1% | $11.1M |
| Free Cash Flow | $293.7M | $377.7M+23.7% | $305.3M+335.5% | $70.1M+1897.4% | -$3.9M+97.8% | -$180.0M-300.0% | -$45.0M+31.1% | -$65.3M+46.3% | -$121.5M-273.8% | -$32.5M-423.9% | -$6.2M+73.2% | -$23.2M-802.6% | -$2.6M+35.2% | -$4.0M+90.1% | -$40.0M-9.5% | -$36.6M |
| Investing Cash Flow | -$248.9M | -$222.7M-52.3% | -$146.2M-22.4% | -$119.4M+37.5% | -$191.1M-131.1% | -$82.7M-690.7% | $14.0M+119.0% | -$73.6M+60.1% | -$184.5M+12.5% | -$210.8M-18.4% | -$178.0M-1061.7% | -$15.3M-33.4% | -$11.5M-57.2% | -$7.3M+33.5% | -$11.0M+77.6% | -$49.0M |
| Financing Cash Flow | -$845.4M | -$595.3M-2026.1% | -$28.0M-105.9% | -$13.6M+66.3% | -$40.3M-199.0% | $40.7M-93.3% | $605.5M+723.8% | $73.5M+944.8% | -$8.7M-102.9% | $304.5M+72.5% | $176.6M+47692.2% | -$371K-109.2% | $4.0M-95.8% | $96.4M+2745.1% | $3.4M-93.9% | $55.1M |
| Share Buybacks | $329.5M | $59.6M | $0 | $0 | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Not reported in any period shown, so not listed: Dividends Paid.
TTM is the trailing twelve months, Q3 FY2025 through Q2 FY2026, summed from the four most recent quarterly filings. A row marked — cannot be summed at all, because a quarter in the window reports no per-share figure; a row marked N/A could be summed, but a quarter in the window does not report that metric.
PODD Financial Ratios
Margins and returns are percentages; the remaining ratios are unitless multiples.
| Metric | FY25 | FY24 | FY23 | FY22 | FY21 | FY20 | FY19 | FY18 | FY17 | FY16 | FY15 | FY14 | FY13 | FY12 | FY11 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross Margin | 71.6%+1.8pp | 69.8%+1.4pp | 68.3%+6.6pp | 61.7%-6.7pp | 68.5%+4.1pp | 64.4%-0.7pp | 65.1%-0.6pp | 65.7%+5.9pp | 59.8%+2.2pp | 57.5%+7.0pp | 50.5%-4.5pp | 55.0%+6.5pp | 48.5%+4.8pp | 43.7%-0.1pp | 43.8% |
| Operating Margin | 17.5%+2.6pp | 14.9%+1.9pp | 13.0%+10.1pp | 2.9%-8.6pp | 11.5%+5.8pp | 5.7%-1.1pp | 6.8%+1.9pp | 4.9%+6.5pp | -1.6%+1.3pp | -2.9%+15.6pp | -18.5%-14.6pp | -3.8%+10.6pp | -14.4%+2.6pp | -17.0%+10.9pp | -27.9% |
| Net Margin | 9.1%-11.1pp | 20.2%+8.0pp | 12.2%+11.8pp | 0.4%-1.2pp | 1.5%+0.8pp | 0.8%-0.8pp | 1.6%+1.0pp | 0.6%+6.4pp | -5.8%+2.1pp | -7.9%+20.0pp | -27.9%-5.6pp | -22.3%+2.0pp | -24.3%+0.3pp | -24.5%+5.6pp | -30.1% |
| Return on Equity | 16.3%-18.2pp | 34.5%+6.4pp | 28.2%+27.2pp | 1.0%-2.1pp | 3.0%+1.9pp | 1.1%-14.1pp | 15.3%+13.7pp | 1.6%+18.5pp | -16.9%+28.9pp | -45.8%+170.1pp | -215.9%-154.5pp | -61.4%-25.3pp | -36.1%+81.3pp | -117.4%-62.0pp | -55.4% |
| Return on Assets | 7.8%-5.8pp | 13.6%+5.6pp | 8.0%+7.8pp | 0.2%-0.6pp | 0.8%+0.5pp | 0.4%-0.7pp | 1.0%+0.7pp | 0.4%+3.6pp | -3.3%+3.0pp | -6.3%+20.4pp | -26.7%-9.4pp | -17.3%-1.7pp | -15.6%+10.6pp | -26.2%-5.5pp | -20.7% |
| Current Ratio | 2.81-0.8x | 3.58+0.1x | 3.51-0.1x | 3.60-2.2x | 5.81-0.2x | 6.01+2.3x | 3.75-0.2x | 3.99-2.3x | 6.24-0.4x | 6.64+3.7x | 2.93-1.8x | 4.700.0x | 4.68+2.4x | 2.28-2.5x | 4.74 |
| Debt-to-Equity | 0.61-0.5x | 1.07-0.8x | 1.86-1.0x | 2.88+0.6x | 2.24+0.5x | 1.73-10.0x | 11.70+8.9x | 2.79-0.8x | 3.57-1.7x | 5.27+0.2x | 5.04+3.1x | 1.96+1.0x | 0.91-1.4x | 2.35+1.0x | 1.31 |
| FCF Margin | 14.0%-0.8pp | 14.7%+10.6pp | 4.1%+4.4pp | -0.3%+16.1pp | -16.4%-11.4pp | -5.0%+3.9pp | -8.8%+12.7pp | -21.6%-14.5pp | -7.0%-5.3pp | -1.7%+7.1pp | -8.8%-7.7pp | -1.1%+1.0pp | -2.1%+16.8pp | -18.9%+5.1pp | -24.0% |
Similar Companies
Where Insulet Corp Ranks
Frequently Asked Questions
What is Insulet Corp's annual revenue?
Insulet Corp (PODD) reported $2.7B in total revenue for fiscal year 2025. This represents a 30.7% change compared to the previous fiscal year. Revenue measures the total income earned from the company's primary business operations before any expenses are deducted.
How fast is Insulet Corp's revenue growing?
Insulet Corp (PODD) revenue grew by 30.7% year-over-year, from $2.1B to $2.7B in fiscal year 2025.
Is Insulet Corp profitable?
Yes, Insulet Corp (PODD) reported a net income of $247.1M in fiscal year 2025, with a net profit margin of 9.1%.
What is Insulet Corp's EBITDA?
Insulet Corp (PODD) had EBITDA of $564.2M in fiscal year 2025, measuring earnings before interest, taxes, depreciation, and amortization.
How much debt does Insulet Corp have?
As of fiscal year 2025, Insulet Corp (PODD) had $716.1M in cash and equivalents against $930.8M in long-term debt.
What is Insulet Corp's gross margin?
Insulet Corp (PODD) had a gross margin of 71.6% in fiscal year 2025, indicating the percentage of revenue retained after direct costs of goods sold.
What is Insulet Corp's operating margin?
Insulet Corp (PODD) had an operating margin of 17.5% in fiscal year 2025, reflecting the profitability of core business operations before interest and taxes.
What is Insulet Corp's net profit margin?
Insulet Corp (PODD) had a net profit margin of 9.1% in fiscal year 2025, representing the share of revenue converted into profit after all expenses.
What is Insulet Corp's return on equity (ROE)?
Insulet Corp (PODD) has a return on equity of 16.3% for fiscal year 2025, measuring how efficiently the company generates profit from shareholder equity.
What is Insulet Corp's free cash flow?
Insulet Corp (PODD) generated $377.7M in free cash flow during fiscal year 2025. This represents a 23.7% change compared to the previous fiscal year. Free cash flow represents the cash a company generates after accounting for capital expenditures, and is widely used to assess financial flexibility and shareholder value.
What is Insulet Corp's operating cash flow?
Insulet Corp (PODD) generated $569.3M in operating cash flow during fiscal year 2025, representing cash generated from core business activities.
What are Insulet Corp's total assets?
Insulet Corp (PODD) had $3.2B in total assets as of fiscal year 2025, including both current and long-term assets.
What are Insulet Corp's capital expenditures?
Insulet Corp (PODD) invested $191.6M in capital expenditures during fiscal year 2025, funding long-term assets and infrastructure.
How much does Insulet Corp spend on research and development?
Insulet Corp (PODD) invested $301.1M in research and development during fiscal year 2025.
What is Insulet Corp's current ratio?
Insulet Corp (PODD) had a current ratio of 2.81 as of fiscal year 2025, which is generally considered healthy.
What is Insulet Corp's debt-to-equity ratio?
Insulet Corp (PODD) had a debt-to-equity ratio of 0.61 as of fiscal year 2025, measuring the company's financial leverage by comparing total debt to shareholder equity.
What is Insulet Corp's return on assets (ROA)?
Insulet Corp (PODD) had a return on assets of 7.8% for fiscal year 2025, measuring how efficiently the company uses its assets to generate profit.
What is Insulet Corp's Altman Z-Score?
Insulet Corp (PODD) has an Altman Z-Score of 5.69, placing it in the Safe Zone (low bankruptcy risk). The Z-Score combines five financial ratios (working capital, retained earnings, EBIT, market capitalization, and revenue relative to total assets) to predict the likelihood of bankruptcy. Scores above 2.99 indicate financial safety while scores below 1.81 suggest financial distress. Learn more in our complete guide to financial health indicators.
What is Insulet Corp's Piotroski F-Score?
Insulet Corp (PODD) has a Piotroski F-Score of 6 out of 9, indicating neutral financial health. The F-Score evaluates nine binary signals across profitability (positive ROA, positive cash flow, improving ROA, earnings quality), leverage (decreasing debt, improving liquidity, no share dilution), and operating efficiency (improving gross margin, improving asset turnover). Scores of 7 to 9 indicate strong and improving fundamentals. Learn more in our complete guide to financial health indicators.
Are Insulet Corp's earnings high quality?
Insulet Corp (PODD) has an earnings quality ratio of 2.30x, considered cash-backed (high quality). This ratio compares operating cash flow to net income. A ratio above 1.0x means the company generates more cash than its reported earnings, indicating sustainable, cash-backed profits. Ratios below 1.0x suggest earnings rely on accounting accruals rather than actual cash generation. Learn more in our complete guide to financial health indicators.
Can Insulet Corp cover its interest payments?
Insulet Corp (PODD) has an interest coverage ratio of 7.98x, meaning it can comfortably cover its interest obligations. This ratio divides operating income by interest expense. Ratios above 5x indicate strong debt-servicing ability, while ratios below 2x suggest the company may face difficulty meeting interest payments if earnings decline. Learn more in our complete guide to financial health indicators.
How financially healthy is Insulet Corp?
Insulet Corp (PODD) scores 74 out of 100 on our Financial Health Score, indicating strong standing within its operating companies peer group. The score is a 0-100 composite of six dimensions (Profitability, Growth, Leverage, Liquidity, Cash Flow, Returns), each ranked as a percentile relative to companies in the same scoring family (banks against banks, REITs against REITs, and so on) rather than across all industries. It rates the quality of the business, not whether the stock is fairly priced, and is not financial advice. Learn more in our complete guide to financial health indicators.